In vivo proton MR three-dimensional T1ρ mapping of human articular cartilage: Initial experience

Radiology

Volumn 229, Issue 1, 2003, Pages 269-274

  Regatte, Ravinder Reddy ^a   Akella, Sarma V S ^a   Borthakur, Arijitt ^a   Kneeland, J Bruce ^a   Reddy, Ravinder ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arthritis; Cartilage; Magnetic resonance (MR); MR; Three dimensional

Indexed keywords

ADULT; ARTICLE; ARTICULAR CARTILAGE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGE RECONSTRUCTION; IN VIVO STUDY; OSTEOARTHRITIS; PATELLOFEMORAL JOINT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; THREE DIMENSIONAL IMAGING; VALIDATION PROCESS;

ADULT; CARTILAGE, ARTICULAR; FEMALE; FEMUR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATELLA;

EID: 0141518350     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2291021041     Document Type: Article

References (28)

1. Grushko G, Schneiderman R, Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect Tissue Res 1989; 19:149-176.
2. Lohmander LS. Articular cartilage and osteoarthrosis: the role of molecular markers to monitor breakdown, repair and disease. J Anat 1994; 184:477-492.
3. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971; 53:523-537.
4. Buckwalter JA, Martin J. Degenerative joint disease. Clin Symp 1995; 47:1-32.
5. Burstein D, Bashir A, Gray ML. MRI techniques in early stages of cartilage disease. Invest Radiol 2000; 35:622-638.
6. Recht MP, Resnick D. MR imaging of articular cartilage: current status and future directions. AJR Am J Roentgenol 1994; 163:283-290.
7. Peterfy CG, Linares R, Steinbach LS. Recent advances in magnetic-resonance-imaging of the musculoskeletal system. Radiol Clin North Am 1994; 32:291-311.
8. 2- as a measure of cartilage degradation. Magn Reson Med 1996; 36:665-673.
9. Burstein D, Velyvis J, Scott KT, et al. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med 2001; 45:36-41.
10. Mlynarik V, Trattnig S, Huber M, Zembsch A, Imhof H. The role of relaxation times in monitoring proteoglycan depletion in articular cartilage. J Magn Reson Imaging 1999; 10:497-502.
11. Lattanzio P, Peermoeller H, Damyanovich A, Marhsall K. In-vitro assessment of nitroxide contrasting agent in early-OA proteoglycan depletion of articular cartilage (abstr). Trans Orthop Res Soc 2000; 25:1024.
12. Reddy R, Insko EK, Noyszewski EA, Dandora R, Kneeland JB, Leigh JS. Sodium MRI of human articular cartilage in vivo. Magn Reson Med 1998; 39:697-701.
13. 23Na MRI and MRS. J Magn Reson 2000; 142:24-31.
14. Shapiro EM, Borthakur A, Gougoutas A, Reddy R. 23Na MRI accurately measures fixed charge density in articular cartilage. Magn Reson Med 2002; 47:284-291.
15. Redfield AG. Nuclear magnetic resonance saturation and rotary saturation in solids. Phys Rev 1955; 98:1787-1809.
16. Aronen HJ, Ramadan UA, Peltonen TK, et al. 3D spin-lock imaging of human gliomas. Magn Reson Imaging 1999; 17:1001-1010.
17. Rizi RR, Charagundla SR, Song HK, et al. Proton T1rho-dispersion imaging of rodent brain at 1.9 T. J Magn Reson Imaging 1998; 8:1090-1096.
18. Markkola AT, Aronen HJ, Paavonen T, et al. Spin lock and magnetization transfer imaging of head and neck tumors. Radiology 1996; 200:369-375.
19. Akella SVS, Regatte RR, Gougoutas AJ, et al. Proteoglycan induced changes in T1ρ-relaxation of articular cartilage at 4 T. Magn Reson Med 2001; 46:419-423.
20. Duvvuri U, Reddy R, Patel SD, Kaufman JH, Kneeland JB, Leigh JS. T1ρ-relaxation in articular cartilage: effects of enzymatic degradation. Magn Reson Med 1997; 38: 863-867.
21. Duvvuri U, Charagundla SR, Kudchodkar SB, et al. Human knee: in vivo T1(rho)-weighted MR imaging at 1.5 T-preliminary experience. Radiology 2001; 220:822-826.
22. Reddy R, Stolpen AH, Leigh JS. Detection of 17O by proton T1 rho dispersion imaging. J Magn Reson B 1995; 108:276-279.
23. Rommel E, Kimmich R. Volume-selective determination of the spin-lattice relaxation time in the rotating frame T1 rho, and T1 rho imaging. Magn Reson Med 1989; 12:209-218.
24. Borthakur A, Shapiro EM, Beers J, Kudchodkar S, Kneeland JB, Reddy R. Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI. Osteoarthritis Cartilage 2000; 8:288-293.
25. U.S. Department of Health and Human Services, Food and Drug Administration, Center for the Devices and Radiological Health. Guidance for the submission of premarket notifications for magnetic resonance diagnostic devices. Washington, DC: Food and Drug Administration, 1998. Available online at www.fda.gov /cdrh/ode/mri340.pdf.
26. Collins CM, Li S, Smith MB. SAR and B1 field distributions in a heterogeneous human head model within a birdcage coil: specific energy absorption rate. Magn Reson Med 1998; 40:847-856.
27. Borthakur A, Hancu I, Boada FE, Shen GX, Shapiro EM, Reddy R. In vivo triple quantum filtered twisted projection sodium MRI of human articular cartilage. J Magn Reson 1999; 141:286-290.
28. Henkelman RM, Hardy PA, Bishop JE, Poon CS, Plewes DB. Why fat is bright in RARE and fast spin-echo imaging. J Magn Reson Imaging 1992; 2:533-540.